en en en en en war en en en en en de en en en en en en en en en en en en en en en en en en it en en en en en en en en en en en en en en en en en en en en en
Pfizer's (PFE) COVID-19 vaccine (BNT162b2) Phase 3 efficacy & safety will have major implications for Pfizer's stock price. Given compelling efficacy signals and no major safety issues to date, we are optimistic about the chances of a potential success in their vaccine.
In addition to Moderna's trials this is something we are watching very closely and believe will be a major catalyst to Pfizer's stock movement.
In addition to our coverage of Pfizer, you may be wondering to yourself how we anticipate the world returning to normalcy. We offer the following: We believe mask requirements may still exist for an extended period of time post vaccine launch (before herd immunity can be reached). The efficacy of vaccines will help determine how long it will take to reach herd immunity and how long the public may need to wear masks for protection. For example, if the Pfizer and Moderna vaccines offer 70% protection against COVID infection, then for every 100 people vaccinated,30 could still be at risk of disease. But note that vaccination may also offer the benefit of reducing the severity of the disease even if it does not prevent infection. As such, while we can't predict the speed of herd immunity, we do believe that efficacy of the vaccine, is the most important metric to watch and we are hopeful we will get there!
Start a Free Trial To Continue Reading
Save 45% With Annual
Why This Stock Is Up 37% This Year
Flagship Pod: Is The Market At A Bottom?
market & industry analysis
The Company Who's Dominating The Space Race
All Categories communication services consumer discretionary crypto energy financials fundamentals health care industrials information technology interactive tools investing strategies market & industry analysis materials news nft portfolio strategy rankings and lists real estate